000			02101 a2200553 4500
005			20250513103620.0
264		0	_c19961216
008			199612s 0 0 eng d
022			_a0002-9513
024	7		_a10.1152/ajpcell.1996.271.4.C1256 _2doi
040			_aNLM _beng _cNLM
100	1		_aLin, H Y
245	0	0	_aPotentiation by thyroxine of interferon-gamma-induced antiviral state requires PKA and PKC activities. _h[electronic resource]
260			_bThe American journal of physiology _cOct 1996
300			_aC1256-61 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aCalmodulin _xpharmacology
650	0	4	_aCarbazoles
650	0	4	_aCyclic AMP _xphysiology
650	0	4	_aCyclic AMP-Dependent Protein Kinase Type II
650	0	4	_aCyclic AMP-Dependent Protein Kinases _xantagonists & inhibitors
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Synergism
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEstrenes _xpharmacology
650	0	4	_aHeLa Cells
650	0	4	_aHumans
650	0	4	_aIndoles _xpharmacology
650	0	4	_aInterferon-gamma _xadministration & dosage
650	0	4	_aL Cells
650	0	4	_aMice
650	0	4	_aProtein Kinase C _xantagonists & inhibitors
650	0	4	_aPyrroles _xpharmacology
650	0	4	_aPyrrolidinones _xpharmacology
650	0	4	_aRhabdoviridae Infections _xphysiopathology
650	0	4	_aStaurosporine _xanalogs & derivatives
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTetradecanoylphorbol Acetate _xpharmacology
650	0	4	_aThyroxine _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aVesicular stomatitis Indiana virus
650	0	4	_aViral Interference _xdrug effects
700	1		_aThacorf, H R
700	1		_aDavis, F B
700	1		_aDavis, P J
773	0		_tThe American journal of physiology _gvol. 271 _gno. 4 Pt 1 _gp. C1256-61
856	4	0	_uhttps://doi.org/10.1152/ajpcell.1996.271.4.C1256 _zAvailable from publisher's website
999			_c8890419 _d8890419